Imara
IPOImara is a biotech company in Boston, United States, founded in 2016. It has raised $94.0M across 2 rounds, most recently a $63.0M Series B in March 2019.
- Headquarters
- Boston, Massachusetts
- Employees
- 11–50
- Founded
- 2016
- Business Model
- B2B
- Website
- imarainc.com
- Total Funding
- $94.0M
- Last Round
- $63.0M Series BMar 2019
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 9 investors for this company. The full record is or through the API.
About
Imara Inc. was a Boston-based clinical-stage biopharmaceutical company dedicated to developing novel therapeutics for sickle cell disease and beta-thalassemia. Founded in 2016, Imara advanced its lead candidate tovinontrine through clinical trials before discontinuing the program in 2022. The company subsequently completed a reverse merger with Enliven Therapeutics in February 2023.
Summary
It lists 11–50 employees. It has raised $94.0M in total across 2 rounds, most recently a $63.0M Series B round in Mar 2019. Investors include OrbiMed, Arix Bioscience and New Enterprise Associates.
Funding History
Mar 2019
Sign up to see all 2 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/imara"><img src="https://indexed.vc/api/badge/company/imara" alt="Imara on Indexed.vc" width="260" height="76" /></a>